Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant To Cut To 2,850 Workers After Bausch + Lomb Deal
Pharmalot
Monday, July 29, 2013 - 1:35pm
tags:
Valeant Pharmaceuticals, layoffs, Bausch & Lomb, M&A
Vertex: Risk-Reward Less Favorable If HCV Pipeline Is In Question
Seeking Alpha
Monday, July 29, 2013 - 1:34pm
tags:
Vertex Pharmaceuticals, hepatitis C, VX-135
Synta Soars on Positive Breast Cancer Drug Trial Results
Bloomberg
Monday, July 29, 2013 - 1:32pm
tags:
Synta Pharmaceuticals, breast cancer, ganetespib
Pfizer's New Structure Could Be The Prelude To A Breakup
Forbes
Monday, July 29, 2013 - 12:34pm
tags:
Pfizer, reorganization
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Monday, July 29, 2013 - 12:27pm
tags:
TearLab, Array Biopharma, Furiex Pharmaceuticals, InterMune, Prosensa, Boston Scientific, Orexigen, Momenta, Ironwood, INSYS Therapeutics, Sequenom, OncoMed, Abraxis, Sarepta, Epizyme, Tesaro, Synta Pharmaceuticals, Bluebird Bio, Exelixis, Lexicon Pharmaceuticals, Intercept Pharma, GTx
Breakthrough Prostate Cancer Treatment May Propel Medivation Into The Black
Forbes
Monday, July 29, 2013 - 12:14pm
tags:
prostate cancer, Medivation, Xtandi
[video] Perrigo's $8.6B Elan Deal Could Save $150M in Taxes
Bloomberg
Monday, July 29, 2013 - 12:01pm
tags:
Perrigo, Elan
Pfizer sells key vaccine cheaply to poor countries
Yahoo/AP
Monday, July 29, 2013 - 10:52am
tags:
Pfizer, vaccines, Prevnar 13
FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
Yahoo
Monday, July 29, 2013 - 10:50am
tags:
FDA, MNK-795, Mallinckrodt, oxycodone, Depomed
Pfizer Splits Up Operations Ahead of Possible Breakup
Bloomberg
Monday, July 29, 2013 - 10:47am
tags:
Pfizer, reorganization
Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship
Yahoo
Monday, July 29, 2013 - 10:46am
tags:
Bristol-Myers Squibb, Samsung BioLogics, drug manufacturing
FDA Is Restricting This Johnson & Johnson Drug
Wall St. Cheat Sheet
Monday, July 29, 2013 - 10:36am
tags:
antifungals, FDA, JNJ, Nizoral
Court’s decision in MS drug patent dispute spells trouble for Teva
MedCity News
Sunday, July 28, 2013 - 11:21am
tags:
Teva, generics, Copaxone
InterMune Successfully Entering Huge Niche Market Unchallenged
Seeking Alpha
Sunday, July 28, 2013 - 11:18am
tags:
InterMune, Esbriet, idiopathic pulmonary fibrosis
Amgen Keeps Dividend Steady
Motley Fool
Sunday, July 28, 2013 - 11:16am
tags:
Amgen
China Biotech In Review: Despite Its China Problems, GlaxoSmithKline Moving Forward With Vaccine Collaboration Plan
Seeking Alpha
Sunday, July 28, 2013 - 11:15am
tags:
GSK, Zhejiang Hisun Pharma, Celsion, Lumenis, BGI Shenzhen
This Week in Biotech
Motley Fool
Sunday, July 28, 2013 - 11:13am
tags:
Array Biopharma, Biocryst, Forrest, Vertex Pharmaceuticals, Teva
Sequenom's 30% Nosedive Leads an Up-and-Down Week in Biotech
Motley Fool
Sunday, July 28, 2013 - 11:12am
tags:
Sequenom
Takeda unblinds ELM-PC 5 phase III study of orteronel in patients with mCRPC
Pharmabiz
Saturday, July 27, 2013 - 11:45am
tags:
Takeda, ELM-PC, prostate cancer
Court overturns patents on Teva's MS drug Copaxone
BusinessWeek
Saturday, July 27, 2013 - 11:27am
tags:
Teva, lawsuits, generics, Copaxone, Mylan, Momenta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.